Apimeds Pharmaceuticals US, Inc
APUS · Healthcare · $6M
After-hours $4.91+1.87%
Price
$9.00
$6.39
Jun 30, 26Sep 28, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
6/'26
Revenue$0M
Operating Income-$6M-54.2%
Net Income-$20M+42.5%
3/'26 vs prev quarter
Company Health
Market Cap$6M
Cash on Hand$278,3715.0% of market cap
Free Cash Flow$-13M-238.5% of market cap
Short Float 3.5% · biweekly · settled 26.08.31
Among 463 Biotechnology peers
LowMedianHigh
PBR0.1xmedian 2.0xROE-54.6%median -54.5%
